These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 29519806)

  • 1. Cancer and platelet crosstalk: opportunities and challenges for aspirin and other antiplatelet agents.
    Xu XR; Yousef GM; Ni H
    Blood; 2018 Apr; 131(16):1777-1789. PubMed ID: 29519806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin and antiplatelet treatments in cancer.
    Tao DL; Tassi Yunga S; Williams CD; McCarty OJT
    Blood; 2021 Jun; 137(23):3201-3211. PubMed ID: 33940597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin prevents colorectal cancer metastasis in mice by splitting the crosstalk between platelets and tumor cells.
    Guillem-Llobat P; Dovizio M; Bruno A; Ricciotti E; Cufino V; Sacco A; Grande R; Alberti S; Arena V; Cirillo M; Patrono C; FitzGerald GA; Steinhilber D; Sgambato A; Patrignani P
    Oncotarget; 2016 May; 7(22):32462-77. PubMed ID: 27074574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin, platelets, and cancer: The point of view of the internist.
    Santilli F; Boccatonda A; Davì G
    Eur J Intern Med; 2016 Oct; 34():11-20. PubMed ID: 27344083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelets as crucial partners for tumor metastasis: from mechanistic aspects to pharmacological targeting.
    Contursi A; Sacco A; Grande R; Dovizio M; Patrignani P
    Cell Mol Life Sci; 2017 Oct; 74(19):3491-3507. PubMed ID: 28488110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin, platelet inhibition and cancer prevention.
    Patrignani P; Patrono C
    Platelets; 2018 Dec; 29(8):779-785. PubMed ID: 29985750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic Agents and Cancer.
    Bruno A; Dovizio M; Tacconelli S; Contursi A; Ballerini P; Patrignani P
    Cancers (Basel); 2018 Jul; 10(8):. PubMed ID: 30065215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.
    Cooke NM; Spillane CD; Sheils O; O'Leary J; Kenny D
    BMC Cancer; 2015 Sep; 15():627. PubMed ID: 26353776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug.
    Mitrugno A; Sylman JL; Rigg RA; Tassi Yunga S; Shatzel JJ; Williams CD; McCarty OJT
    Platelets; 2018 Dec; 29(8):773-778. PubMed ID: 29265902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.
    Mitrugno A; Sylman JL; Ngo AT; Pang J; Sears RC; Williams CD; McCarty OJ
    Am J Physiol Cell Physiol; 2017 Feb; 312(2):C176-C189. PubMed ID: 27903583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and extracellular vesicles and their cross talk with cancer.
    Lazar S; Goldfinger LE
    Blood; 2021 Jun; 137(23):3192-3200. PubMed ID: 33940593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis.
    Johnson KE; Ceglowski JR; Roweth HG; Forward JA; Tippy MD; El-Husayni S; Kulenthirarajan R; Malloy MW; Machlus KR; Chen WY; Italiano JE; Battinelli EM
    Blood Adv; 2019 Jan; 3(2):198-211. PubMed ID: 30670536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
    Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
    Front Immunol; 2021; 12():807600. PubMed ID: 34987523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.
    Mikami J; Kurokawa Y; Takahashi T; Miyazaki Y; Yamasaki M; Miyata H; Nakajima K; Takiguchi S; Mori M; Doki Y
    Gastric Cancer; 2016 Jul; 19(3):817-26. PubMed ID: 26486505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiplatelet effect of aspirin in patients with coronary artery disease.
    Grove EL
    Dan Med J; 2012 Sep; 59(9):B4506. PubMed ID: 22951204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Platelet Lifeline to Cancer: Challenges and Opportunities.
    Haemmerle M; Stone RL; Menter DG; Afshar-Kharghan V; Sood AK
    Cancer Cell; 2018 Jun; 33(6):965-983. PubMed ID: 29657130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress-related mechanisms affecting response to aspirin in diabetes mellitus.
    Santilli F; Lapenna D; La Barba S; Davì G
    Free Radic Biol Med; 2015 Mar; 80():101-10. PubMed ID: 25530150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombosis and coronary disease: neutrophils, nitric oxide and aspirin].
    López-Farré A; Farré J; Sánchez de Miguel L; Romero J; Gómez J; Rico L; Casado S
    Rev Esp Cardiol; 1998 Mar; 51(3):171-7. PubMed ID: 9577162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.